CD4 and neoplasm: We found that the number of CD4+ and CD8+ T cells in the peripheral blood of tumor-bearing mice treated with Ad-hLF significantly increased compared with that of the control group, which suggests that Ad-hLF increases the expression of CD4+ and CD8+ T cells and may activate them.